Abstract: Duodenal adenocarcinoma, a very rare malignant gastrointestinal tumor, mainly metastasizes via the lymphatic system. Metastases from duodenal adenocarcinomas to the breast are very uncommon.
INTRODUCTION
D uodenal adenocarcinoma is rare: although most small bowel adenocarcinomas (56%) arise in the duodenum, small bowel cancers account for only 2% of all gastrointestinal cancers in the United States. 1, 2 It mainly metastasizes via the lymphatic system; lymph node metastases are associated with a poor prognosis. 3 Here, we report a case of a young woman who we diagnosed as having a breast metastasis from a duodenal adenocarcinoma.
CASE PRESENTATION
A 31-year-old woman was admitted to our hospital because of a left breast tumor. Her family history was noncontributory. She had undergone pancreaticoduodenectomy for a duodenal adenocarcinoma 18 months previously and had received 6 courses of postoperative chemotherapy. A chest CT examination 4 months prior to the current presentation had shown no abnormalities. Physical examination revealed a 2.5-cm-diameter tumor in the outer lower quadrant of the left breast. Mammography showed a hyperdense mass with a circumscribed border ( Figure 1 ) and ultrasound showed a 23-mm Â 14-mm nodular low echo in the outer lower quadrant of the left breast with a non-uniform texture and a well-defined boundary. Color Doppler flow images displayed blood flow. Multiple axillary lymph nodes were identified; the largest measuring 11 mm Â 5 mm ( Figure 2 ). CT examination showed a soft 22-mm Â 17-mm lesion of tissue-like density with a central patchy low-density area in the lower quadrant of the left breast with a well-defined boundary. Lymph nodes were identified in the left axilla ( Figure 3B ). Local excision was performed to remove the breast lesion ( Figure 3A) , the provisional diagnosis being invasive carcinoma. Pathologic examination of the resected specimen showed poorly differentiated adenocarcinoma ( Figure 4A ). Immunohistochemical analysis revealed that mammary tumor cells were positive for CDX2 ( Figure 5A ), villin ( Figure 5B ), cytokeratin 20 ( Figure 5C ), and cytokeratin 7 ( Figure 5D ), but negative for estrogen receptors ( Figure 5E ) and progesterone receptors ( Figure 5F ) and human epidermal growth factor receptor-2 ( Figure 5G) ; 70% of the cells were Ki-67 positive ( Figure 5H) . Comparison of the pathological findings with those of the previous duodenal adenocarcinoma ( Figure 4B ) resulted in a final diagnosis of a metastasis to the breast from duodenal adenocarcinoma. The patient was then treated with palliative chemotherapy. At the time of submission of our manuscript, the patient was tolerating the new chemotherapy regimen well and had been followed for 2 months after a definitive diagnosis had been made. underwent resection of the breast tumor and comparison of the pathological sections of the excised specimen with those of the previous duodenal adenocarcinoma resulted in a diagnosis of a metastasis from the duodenal carcinoma to the breast. The correct diagnosis was, therefore, crucial in avoiding unnecessary surgical interventions.
A diagnosis of metastasis to the breast must be confirmed by pathologic examination. When a patient's history reveals a previous primary malignancy, the pathological characteristics, including immunohistochemical findings, of a breast lesion should be compared with those of the previous primary tumor. A specific diagnosis cannot be made by imaging procedures, such as mammography, ultrasound or CT. On mammography, breast metastases reportedly present as round lesions with smooth margins. 10 The imaging findings in our case suggested a benign tumor; however, pathological examination resulted in a diagnosis of metastatic poorly differentiated adenocarcinoma. Thus, the final diagnosis depends on surgical resection or biopsy. Breast cancer can metastatic to the duodenum, 11 there might be some relationship between the 2 organ, but the mechanism is not yet understood and needs further study.
CONCLUSIONS
Our patient illustrates that metastasis to the breast from duodenal adenocarcinoma does occur. Despite its rarity, it should be considered in the differential diagnosis of an apparent primary mammary carcinoma because the treatment and prognosis differ significantly. Those working in the field of breast diagnosis and therapy should be aware of the possibility of metastases to the breast.
